Singapore markets closed

Global Medical REIT Inc. (GMRE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
8.90+0.01 (+0.11%)
At close: 04:00PM EDT
8.95 +0.05 (+0.56%)
After hours: 05:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 583.73M
Enterprise value 1.28B
Trailing P/E 38.70
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.17
Price/book (mrq)1.17
Enterprise value/revenue 9.18
Enterprise value/EBITDA 11.72

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 33.61%
S&P500 52-week change 326.49%
52-week high 311.59
52-week low 37.98
50-day moving average 38.51
200-day moving average 39.40

Share statistics

Avg vol (3-month) 3417.83k
Avg vol (10-day) 3407.68k
Shares outstanding 565.59M
Implied shares outstanding 62.54M
Float 861.81M
% held by insiders 15.76%
% held by institutions 158.15%
Shares short (30 Apr 2024) 41.25M
Short ratio (30 Apr 2024) 43.28
Short % of float (30 Apr 2024) 42.02%
Short % of shares outstanding (30 Apr 2024) 41.90%
Shares short (prior month 28 Mar 2024) 41.23M

Dividends & splits

Forward annual dividend rate 40.84
Forward annual dividend yield 49.44%
Trailing annual dividend rate 30.84
Trailing annual dividend yield 39.45%
5-year average dividend yield 47.13
Payout ratio 4365.22%
Dividend date 309 Apr 2024
Ex-dividend date 421 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.82%
Operating margin (ttm)26.21%

Management effectiveness

Return on assets (ttm)1.77%
Return on equity (ttm)3.57%

Income statement

Revenue (ttm)139.94M
Revenue per share (ttm)2.13
Quarterly revenue growth (yoy)-3.10%
Gross profit (ttm)N/A
EBITDA 90.32M
Net income avi to common (ttm)14.91M
Diluted EPS (ttm)0.23
Quarterly earnings growth (yoy)5.70%

Balance sheet

Total cash (mrq)30.62M
Total cash per share (mrq)0.47
Total debt (mrq)625.6M
Total debt/equity (mrq)104.77%
Current ratio (mrq)1.96
Book value per share (mrq)7.62

Cash flow statement

Operating cash flow (ttm)66.96M
Levered free cash flow (ttm)81.66M